Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

Trial Identifier:	D7000C00004
Sponsor:	AstraZeneca
Start Date:	May 2023
Primary Completion Date:	August 2024
Study Completion Date:	August 2024
Condition:	COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, AL	Anniston, AL, US, 36207
US, AL	Cullman, AL, US, 35055
US, AZ	Scottsdale, AZ, US, 85260
US, Florida	Orlando, Florida, US, 32819

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.